XML 103 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONTINGENCIES (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended 12 Months Ended
Jun. 30, 2013
Proceeding
Dec. 31, 2012
Subsequent Event [Line Items]    
China Antitrust Review As previously announced, the Company is fully cooperating with the Bureau of Price Supervision and Anti-Monopoly of China's National Development and Reform Commission (“NDRC”) in its recent antitrust review of the infant formula industry's practices relating to resale prices (“China Antitrust Review”).  Accordingly, the Company agreed to reduce the ex-factory price of certain products to its direct customers in China. The Company cannot predict what the NDRC's final resolution of this matter will be. Under China law, the NDRC has complete discretion, among other actions, to 1) issue an order prohibiting future conduct deemed illegal; and/or 2) confiscate proceeds deemed illegally obtained; and/or 3) assess a penalty in the range of 1 - 10% of a company's prior year sales in China. In 2012, MJN recorded approximately $800 million of sales in China.  
Approx2012SalesinChina   $ 800
Minimum number of proceedings that could have a material impact 1